IGF1 and Parkinson disease: Since E2 mediates neuroprotective effects through IGF1‐IGFR signalling, we evaluated synergistic and antagonistic interactions between IGF1R genes and genes for neurodegeneration implicated in amyotrophic lateral sclerosis and Alzheimer's, Huntington's, Parkinson's and prion diseases.